A new opinion piece published in Health Affairs Forefront raises questions around current approaches to assess drug safety and effectiveness in people with obesity.
Tag: Prescription Drug
Antipsychotic Medication Prescriptions for Children Sharply Decline
Rutgers Institute for Health researchers observe decrease in use of antipsychotic medications in children since early 2000s.
Nearly ½ of parents have leftover prescription medications at home
Many children live in homes with unused prescription drugs and expired medications, a new national poll suggests.
ACR Co-Authors Amicus Brief in Support of North Dakota Regulating PBM Industry
The Alliance for Transparent & Affordable Prescriptions (ATAP), the Community Oncology Alliance (COA), and American Pharmacies filed an amicus brief with the 8th Circuit Court of Appeals in support of North Dakota’s efforts to regulate practices of pharmacy benefit managers (PBMs).
Drug rebates for insurers tied to higher costs for patients, especially the uninsured
The study found that rebates were associated with increases in out-of-pocket costs for patients by an average of $6 for those with commercial insurance, $13 for Medicare patients and $39 for the uninsured.
Most dollars spent on top-selling orphan drugs don’t go to treat people with rare diseases
Pharmaceutical companies get special protection from the FDA for orphan drugs aimed at rare diseases, but a study shows high spending for common diseases for some such drugs. Just 21% of the total dollars spent in 2018 on 15 top-selling partial orphan drugs went to the treatment of rare diseases, while more than 70% went to the treatment of common diseases.
Big drug costs for small patients with rare diseases, study finds
Only about one in every 170 children take them. But “orphan drugs” accounted for 1 in every 15 private insurance dollars spent on children’s health care in the United States in 2018, according to a new study. That’s up 65% from just five years before.
‘One size fits all’ medication approach doesn’t work in pregnancy
New research led by the University of South Australia shows that a blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk for the rest of their lives.
First FDA-approved drug for thyroid eye disease effective regardless of age, gender
Teprotumumab, the first FDA-approved medicine for thyroid eye disease, provides significant improvement in eye bulging, regardless of patient gender, age or smoking status, according to a study accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Poll reveals risky use of antibiotics by some older adults, and opportunities for providers to improve
Half of older Americans got help from the infection-fighting power of antibiotics in the past two years, a new poll finds, but a sizable minority didn’t follow the instructions on their pill bottle. And one in five say that in the past, they’ve engaged in a risky practice: taking leftover antibiotics without checking with a medical professional.
Long delays prescribing new antibiotics hinder market for needed drugs
MADISON, Wis. — U.S. hospitals wait over a year on average to begin prescribing newly developed antibiotics, a delay that might threaten the supply or discourage future development of needed drugs. A survey of how 132 hospitals prescribed six new…